The most common GLP-1 side effects are gastrointestinal upset: nausea, vomiting, diarrhea and constipation
There is significant room for growth, and it is projected that by 2030, around 35% of diabetes patients in the United States will be using GLP-1 medications, considering that about 65% of T2D patients also have obesity issues
NAION is rare, and not every vision problem is a lawsuit
8 Based on survey responses of 166 participants in a 6-month clinical trial who had overweight or obesity, and were taking semaglutide/tirzepatide for weight loss through Weight Watchers Clinic and provided the GLP-1 Success Program
Does insurance cover oral semaglutide
Private insurance: Most commercial plans cover Jardiance when prescribed for diabetes, heart failure, or kidney disease